Table 1 The relationship of ATP6V1F expression with clinicopathological variables of HCC

Status

Alive

132

109

0.312

Dead

53

77

Age

Mean (SD)

58.7 (14. 1)

Median [MIN, MAX]

60.2 (12.9)

61[61, 85]

0.014

61 [17, 90]

60

Gender

FEMALE

61

126

MALE

124

81

0.971

ASIAN

77

6

BLACK

11

91

WHITE

93

2

AMERICAN INDIAN

pT_stage

T1

102

0.456

T2

40

T2b

1

T3

20

25

T3a

12

17

T3b

2

4

T4

6

7

TX

1

T2a

1

pN_stage

N0

123

129

0.249

NX

62

52

N1

pM_stage

M0

128

138

0.381

M1

2

2

MX

55

46

pTNM_stage

I

95

76

0.556

II

40

46

III

2

1

IIIA

27

38

IIIB

2

6

IIIC

3

6

IV

1

1

IVB

1

1

IVA

1

Grade

G1

35

20

0.362

G2

97

80

G3

48

74

G4

3

9

New_tumor_ event_type

Primary

7

0.003

Recurrence

76

Non-radiation

128

0.267

Radiation_therapy

Radiation

1

0.535

Neoadjuvant

1

1

No neoadjuvant

184

185

1

Chemotherapy

15

14

Chemotherapy:

1

Hormone Therapy

Chemotherapy:Targeted

1

1

Molecular therapy

Other. specify in notes

1

Ancillary

1

Chemotherapy:Hormone Therapy:Other specify in notes

1

Targeted Molecular therapy

5

1